Mobilat (Mucopolysaccharide Polysulfuric Acid Ester, Salicylic Acid, Suprarenal Extract)

The product combines a mucopolysaccharide polysulfuric acid ester that influences extracellular matrix remodeling, salicylic acid that provides keratolytic and anti‑inflammatory effects by inhibiting cyclooxygenase enzymes, and suprarenal extract that contributes adrenal‑derived anti‑inflammatory activity, together promoting exfoliation and reducing skin inflammation.

The dosage of Mobilat is determined by the prescribing clinician based on the specific skin condition, severity, and patient factors. Typically, a thin layer is applied to the affected area once or twice daily, but exact instructions should follow the healthcare provider’s guidance.

Safety of Mobilat in pregnancy or while breastfeeding has not been definitively established. Women who are pregnant, planning to become pregnant, or nursing should discuss potential risks and benefits with their healthcare professional before using the product.

To place an order, submit an enquiry on the Mobilat product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Mobilat combines keratolytic salicylic acid with a mucopolysaccharide ester and adrenal extract, offering both exfoliation and anti‑inflammatory benefits. Compared with standard salicylic acid gels, it may provide additional soothing effects, while differing from retinoids by having a lower irritation profile but also a slower onset of action.

Mobilat should be stored at temperatures below 25 °C, in its original packaging, protected from moisture and direct sunlight. Ensure the container is tightly closed to maintain product stability.

Mobilat is a topical gel applied to clean, dry skin. A thin, even layer should be spread over the affected area, usually once or twice daily as directed by a healthcare professional. Hands should be washed after application to avoid accidental contact with eyes or mucous membranes.

Serious risks, though rare, include severe allergic reactions such as swelling, hives, or difficulty breathing, extensive skin ulceration from over‑use, and secondary bacterial infection of compromised skin. Any signs of these reactions require immediate medical attention.

Individuals with known hypersensitivity to any component of Mobilat, those with active skin infections at the intended site of application, or patients using extensive occlusive dressings should avoid the product unless advised otherwise by a clinician.